Guillermo Garcia-Manero, MD Professor, Department of Leukemia, Division of Cancer Medicine Chief, Section of Myelodysplastic Syndromes, Department of Leukemia, Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, TX
Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, explores imetelstat trial results of patients with transfusion-dependent lower-risk myelodysplastic syndromes who experience failure to or are ineligible for treatment with erythropoiesis-stimulating agents.
Supported through funding by
To sign up for our newsletter or print publications, please enter your contact information below.